-transparent.png){kind=logo}
A patient receiving antihypertensive therapy developed acute intravascular hemolysis and died. Hemolysis was due to an immune process associated with antibody to thiazide. Only two other cases have been reported. Thiazide-induced hemolysis appears to be confined to those patients treated concommitantly with methyldopa.
Related Publications
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
July 1981,
American journal of clinical pathology,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
July 1994,
American journal of hematology,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
February 1991,
Transfusion,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
January 1992,
Immunohematology,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
January 1982,
Transfusion,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
August 1975,
JAMA,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
December 2007,
Chest,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
October 2013,
Transfusion,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
January 1985,
Haematologica,
M L Beck, and
J F Cline, and
J T Hardman, and
L S Racela, and
J W Davis
January 2014,
Medicina clinica,
